163 related articles for article (PubMed ID: 9326284)
1. Tau released from paired helical filaments with formic acid or guanidine is susceptible to calpain-mediated proteolysis.
Yang LS; Gordon-Krajcer W; Ksiezak-Reding H
J Neurochem; 1997 Oct; 69(4):1548-58. PubMed ID: 9326284
[TBL] [Abstract][Full Text] [Related]
2. Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments.
Yang LS; Ksiezak-Reding H
Eur J Biochem; 1995 Oct; 233(1):9-17. PubMed ID: 7588778
[TBL] [Abstract][Full Text] [Related]
3. Conformation of paired helical filaments blocks dephosphorylation of epitopes shared with fetal tau except Ser199/202 and Ser202/Thr205.
Gordon-Krajcer W; Yang L; Ksiezak-Reding H
Brain Res; 2000 Feb; 856(1-2):163-75. PubMed ID: 10677623
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF-tau.
Mercken M; Grynspan F; Nixon RA
FEBS Lett; 1995 Jul; 368(1):10-4. PubMed ID: 7615058
[TBL] [Abstract][Full Text] [Related]
5. The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis.
von Bergen M; Barghorn S; Müller SA; Pickhardt M; Biernat J; Mandelkow EM; Davies P; Aebi U; Mandelkow E
Biochemistry; 2006 May; 45(20):6446-57. PubMed ID: 16700555
[TBL] [Abstract][Full Text] [Related]
6. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
[TBL] [Abstract][Full Text] [Related]
7. Neurofilament monoclonal antibodies RT97 and 8D8 recognize different modified epitopes in paired helical filament-tau in Alzheimer's disease.
Brion JP; Couck AM; Robertson J; Loviny TL; Anderton BH
J Neurochem; 1993 Apr; 60(4):1372-82. PubMed ID: 7681101
[TBL] [Abstract][Full Text] [Related]
8. Immunological characterization of the region of tau protein that is bound to Alzheimer paired helical filaments.
Caputo CB; Wischik C; Novak M; Scott CW; Brunner WF; De Garcini EM; Lo MM; Norris TE; Salama AI
Neurobiol Aging; 1992; 13(2):267-74. PubMed ID: 1381814
[TBL] [Abstract][Full Text] [Related]
9. New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry.
Hanger DP; Betts JC; Loviny TL; Blackstock WP; Anderton BH
J Neurochem; 1998 Dec; 71(6):2465-76. PubMed ID: 9832145
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes.
Kondratick CM; Vandré DD
J Neurochem; 1996 Dec; 67(6):2405-16. PubMed ID: 8931473
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody PHF-9 recognizes phosphorylated serine 404 of tau protein and labels paired helical filaments.
Zemlan FP; Dean GE
J Neurosci Res; 1996 Oct; 46(1):90-7. PubMed ID: 8892109
[TBL] [Abstract][Full Text] [Related]
12. The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments.
Kenessey A; Yen SH
Brain Res; 1993 Nov; 629(1):40-6. PubMed ID: 8287279
[TBL] [Abstract][Full Text] [Related]
13. Beta-amyloid and ionophore A23187 evoke tau hyperphosphorylation by distinct intracellular pathways: differential involvement of the calpain/protein kinase C system.
Shea TB; Prabhakar S; Ekinci FJ
J Neurosci Res; 1997 Sep; 49(6):759-68. PubMed ID: 9335263
[TBL] [Abstract][Full Text] [Related]
14. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease.
Jicha GA; Lane E; Vincent I; Otvos L; Hoffmann R; Davies P
J Neurochem; 1997 Nov; 69(5):2087-95. PubMed ID: 9349554
[TBL] [Abstract][Full Text] [Related]
15. Sulfo-glycosaminoglycan content affects PHF-tau solubility and allows the identification of different types of PHFs.
Hernández F; Pérez M; Lucas JJ; Avila J
Brain Res; 2002 May; 935(1-2):65-72. PubMed ID: 12062474
[TBL] [Abstract][Full Text] [Related]
16. Amino acid residues 226-240 of tau, which encompass the first Lys-Ser-Pro site of tau, are partially phosphorylated in Alzheimer paired helical filament-tau.
Liu WK; Dickson DW; Yen SH
J Neurochem; 1994 Mar; 62(3):1055-61. PubMed ID: 7509372
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.
Keck S; Nitsch R; Grune T; Ullrich O
J Neurochem; 2003 Apr; 85(1):115-22. PubMed ID: 12641733
[TBL] [Abstract][Full Text] [Related]
18. The state of phosphorylation of normal adult brain tau, fetal tau, and tau from Alzheimer paired helical filaments at amino acid residue Ser262.
Liu WK; Yen SH
J Neurochem; 1996 Mar; 66(3):1131-9. PubMed ID: 8769876
[TBL] [Abstract][Full Text] [Related]
19. Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments.
Ksiezak-Reding H; Liu WK; Yen SH
Brain Res; 1992 Dec; 597(2):209-19. PubMed ID: 1472994
[TBL] [Abstract][Full Text] [Related]
20. Induction of Alzheimer-specific Tau epitope AT100 in apoptotic human fetal astrocytes.
Ksiezak-Reding H; He D; Gordon-Krajcer W; Kress Y; Lee S; Dickson DW
Cell Motil Cytoskeleton; 2000 Nov; 47(3):236-52. PubMed ID: 11056524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
